Veeva Systems (VEEV) Liabilities and Shareholders Equity (2013 - 2026)
Veeva Systems' (VEEV) quarterly Liabilities and Shareholders Equity came in at $9.1 billion in Q2 2026, up 17.57% year-on-year from $7.8 billion in Q2 2025, and up 1.67% quarter-over-quarter from $9.0 billion in Q1 2026.
Veeva Systems (VEEV) Liabilities and Shareholders Equity (2013 - 2026) Analysis & Trends
Veeva Systems' Liabilities and Shareholders Equity history runs 14 years deep, the most recent figure standing at $9.1 billion for Q2 2026.
- On a quarterly basis, Liabilities and Shareholders Equity rose 17.57% year-over-year to $9.1 billion in Q2 2026; TTM through Apr 2026 was $34.2 billion, a 22.65% increase from a year earlier, with the FY2026 full-year figure at $9.0 billion, up 22.34% from the prior year.
- Liabilities and Shareholders Equity improved to $9.1 billion in Q2 2026 per VEEV's latest filing, from $9.0 billion in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $9.1 billion in Q2 2026 and bottomed at $3.8 billion in Q1 2022.
- The 5-year median for Liabilities and Shareholders Equity is $6.0 billion (2024), against an average of $6.1 billion.
- Across the five-year window, Liabilities and Shareholders Equity gained 27.0% in 2023 and rose 17.57% in 2026, its largest moves.
- Year by year, Liabilities and Shareholders Equity stood at $4.2 billion in 2022, then climbed by 24.94% to $5.2 billion in 2023, then gained by 23.48% to $6.5 billion in 2024, then rose by 25.48% to $8.1 billion in 2025, then climbed by 12.75% to $9.1 billion in 2026.
- Per Business Quant, the three latest VEEV Liabilities and Shareholders Equity figures stand at $9.1 billion (Q2 2026), $9.0 billion (Q1 2026), and $8.1 billion (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.43 Bn | 24.12 Bn | 662.02 Mn | 9.13 Bn |
| 2 | BrightSpring Health Services | 14.97 Bn | 14.07 Bn | 482.22 Mn | 6.21 Bn |
| 3 | Healthequity | 8.13 Bn | 7.86 Bn | 256.31 Mn | 3.31 Bn |
| 4 | 10x Genomics | 5.98 Bn | 5.44 Bn | 106.18 Mn | 1.02 Bn |
| 5 | Hinge Health | 5.96 Bn | 5.64 Bn | 154.23 Mn | 728.77 Mn |
| 6 | Waystar Holding | 4.43 Bn | 4.37 Bn | 216.84 Mn | 5.84 Bn |
| 7 | MiniMed | 4.38 Bn | 4.08 Bn | 480.00 Mn | 4.63 Bn |
| 8 | Doximity | 3.91 Bn | 3.16 Bn | 125.97 Mn | 1.12 Bn |
| 9 | Privia Health | 3.19 Bn | 2.77 Bn | - | 1.42 Bn |
| 10 | Omnicell | 1.89 Bn | 1.66 Bn | 140.36 Mn | 2.00 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 9.13 Bn |
| Jan 31, 2026 | 8.98 Bn |
| Oct 31, 2025 | 8.10 Bn |
| Jul 31, 2025 | 8.00 Bn |
| Apr 30, 2025 | 7.77 Bn |
| Jan 31, 2025 | 7.34 Bn |
| Oct 31, 2024 | 6.45 Bn |
| Jul 31, 2024 | 6.33 Bn |
| Apr 30, 2024 | 6.19 Bn |
| Jan 31, 2024 | 5.91 Bn |
| Oct 31, 2023 | 5.23 Bn |
| Jul 31, 2023 | 5.23 Bn |
| Apr 30, 2023 | 5.02 Bn |
| Jan 31, 2023 | 4.80 Bn |
| Oct 31, 2022 | 4.18 Bn |
| Jul 31, 2022 | 4.12 Bn |
| Apr 30, 2022 | 4.01 Bn |
| Jan 31, 2022 | 3.82 Bn |
| Oct 31, 2021 | 3.37 Bn |
| Jul 31, 2021 | 3.35 Bn |